Works citing this work

2 works

Work: Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

1. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   ArticleCAR-T cell therapy researchHeliyon20241 citations

   ABIABI:AkademIndex/openalex/2026.other.102962

2. The role and prognostic value of the interleukin 2 gene at multiple myeloma

   G. Z. Makhamadaliyeva, A. A. Kayumov, Nilufar Akhrarova +1

   ArticleMultiple Myeloma Research and TreatmentsMedicine and ecology20240 citations

   ABIABI:AkademIndex/openalex/2024.article.008843